Pharmacy Practice & Operations
Health-System Pharmacy
Pharmacy practice and leadership in hospitals and integrated health systems.
Health-System Pharmacy at a glance
- About this topic
- Pharmacy practice and leadership in hospitals and integrated health systems.
- In the Knowledge Hub
- Content on this topic is in development.
- Live intelligence
- Tracked from official sources on 503B outsourcing facilities, Drug shortages and USP compounding standards.
- Latest official record
- Drug shortage update: Liraglutide Injection — Current (opens the source in a new tab) (U.S. Food and Drug Administration (Drug Shortages), Sep 21, 2026)
General professional education. Not accredited continuing education, and not clinical, legal or financial advice.
Articles and resources
Content on this topic is in development
We publish carefully and only when content is genuinely useful. Get updates when new insights are published, or propose a contribution.
What is changing in this area right now?
Topic intelligenceOfficial records and reference tools from NPHLA Intelligence on the subjects closest to this topic.
- Drug shortage update: Liraglutide Injection — Current (opens the source in a new tab)
Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-13). Company: Novo Nordisk, Inc.. Estimated shortage duration: TBD
- Drug shortage update: Liraglutide Injection — Current (opens the source in a new tab)
Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-12). Company: Novo Nordisk, Inc.. Estimated shortage duration: TBD
- Drug shortage update: Liraglutide Injection — Current (opens the source in a new tab)
Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-22). Company: Novo Nordisk, Inc.. Distributed by Teva
- Drug shortage update: Liraglutide Injection — Current (opens the source in a new tab)
Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15). Company: Novo Nordisk, Inc.. Product will be available until discontinuation in January 2027
- Drug shortage update: Liraglutide Injection — Current (opens the source in a new tab)
Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-20). Company: Novo Nordisk, Inc.. Distributed by Teva
- Sodium Chloride Flush Recall: Spectra Medical Removes Sodium Chloride Injection USP Ampules (opens the source in a new tab)
Spectra Medical Devices is removing Sodium Chloride Flush products that were manufactured by Huons Co,. Ltd.